Arlo Technologies was downgraded to neutral due to increasing near-term risks despite showing strong 20% year-over-year growth in subscription revenue in Q3. However, hardware sales declined by 11% year-over-year, and channel inventory levels increased significantly, raising concerns about the subscriber pipeline. The stock trades at an attractive valuation of 10.8 times FY27 ex-cash P/E, but the weakening hardware sales and macroeconomic challenges suggest caution. Investors are advised to consider trimming exposure ahead of the holiday season due to these risks.
Arlo Technologies is noted for its 20% year-over-year subscription revenue growth in Q3, despite challenges in hardware sales and channel inventory. For readers following the Technology sector, here is Pluang's market snapshot as of Nov 09, 2026 20:51 WIB: out of 150 priced US tech stocks, 100 rose and 42 fell today. Notable movers include VERI at USD 0.50 with a 3.43% gain and a typical hold time of 17 days, STM at USD 43.13 up 3.38% with a 67-day hold, and MSTR at USD 124.60 down 3.36% with a 115-day hold.
Neo Security, Inc. has launched Neoverse, a free AI software intelligence engine that researches and classifies over 4 million AI apps, extensions, and servers to assess their capabilities and security risks. Integrated into Neo's platform, Neoverse ...
AnorTech Inc. completed a $7.55 million share exchange with Nasdaq-listed Greenland Mines, increasing Greenland Mines' ownership in AnorTech to 19.9%. Greenland Mines acquired over 25 million AnorTech shares in exchange for Greenland Mines shares val...
Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...
Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...
